Trinity Biotech reported $15.86M in Sales Revenues for its fiscal quarter ending in December of 2024.


Sales Change Date
Abbott USD 11.42B 1.06B Jun/2025
Bayer EUR 10.74B 3B Jun/2025
Bio-Rad Laboratories USD 651.6M 66.2M Jun/2025
EDAP TMS EUR 20.32M 7.22M Dec/2024
J&J USD 23.74B 1.85B Jun/2025
Roche Holding CHF 31.64B 883M Dec/2024
Siemens EUR 19.38B 380M Jun/2025
Thermo Fisher Scientific USD 10.85B 490M Jun/2025
Tosoh JPY 245.13B 22.56B Jun/2025
Trinity Biotech USD 15.86M 708K Dec/2024
Veracyte USD 130.16M 15.69M Jun/2025